EUVIMEDEUVIMED entdecken
Open Access

Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice

Sabrina Mendes iD, Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, Clara Couto Fernandez iD, Maria Marta Figueiredo, Mauro Martins Teixeira, Robson Augusto Souza Dos Santos, Pedro Pires Goulart Guimarães, Frédéric Frézard iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00835-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Sabrina Mendes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Liposomes, Viral Load, Lung, Angiotensin I. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To effectively reduce the health impact of coronavirus disease (COVID-19), it is essential to adopt comprehensive strategies to protect individuals from severe acute respiratory syndrome. In that sense, much effort has been devoted to the discovery and repurposing of effective antiviral and anti-inflammatory molecules. The endogenous peptide angiotensin-(1-7) [Ang-(1-7)] has been recently proposed as a promising anti-inflammatory agent to control respiratory infections. Liposomes also emerged as a safe and effective drug carrier system for local drug delivery to the lungs. In this context, the aim of this study was to develop a liposomal formulation of Ang-(1-7) [LAng (1-7)] and investigate its impact on animal survival as well as its antiviral and anti-inflammatory efficacies after intranasal administration in transgenic K18-hACE2 mice infected with SARS-CoV-2. The liposomal formulation was prepared by the ethanol injection method, exhibiting a mean diameter of 100 nm and a polydispersity index of 0.1. Following treatment of infected mice every 12 hours for 5 days, LAng (1-7) extended animal survival compared to the control groups that received either empty liposomes, free Ang-(1-7), or phosphate-buffered saline. Furthermore, the treatment with LAng (1-7) significantly decreased the viral load, as well as IL-6 and tumor necrosis factor levels in the lungs. Conventional treatment with remdesivir by parenteral route used as a positive control promoted similar effects, leading to improved survival rates and reduced viral load in the lungs without significant effects on IL-6 level. In conclusion, liposomal Ang-(1-7) emerges as a promising formulation to improve the treatment and decrease the severity of respiratory infections, such as COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesViral LoadLungAngiotensin IAdministration, IntranasalSARS-CoV-2Mice, TransgenicCOVID-19Angiotensin-Converting Enzyme 2COVID-19 Drug TreatmentPeptide FragmentsAntiviral AgentsAnimalsMiceInterleukin-6InflammationAnti-Inflammatory AgentsHumans

Stichwörter der Autor:innen

COVID-19K18-hACE2 miceSARS-CoV-2angiotensin-(1-7)intranasal routeliposomesremdesivir

Substanzen

angiotensin I (1-7)LiposomesAngiotensin IAngiotensin-Converting Enzyme 2Peptide FragmentsAntiviral AgentsInterleukin-6Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Department of Biochemistry and Immunology, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • State University of Minas Gerais, Divinopolis, Minas Gerais, Brazil.

ORCID-Profile: Sabrina Mendes, Clara Couto Fernandez, Frédéric Frézard

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Zitieren

APA

Mendes, S., Guimarães, L. C., Costa, P. A. C., Fernandez, C. C., Figueiredo, M. M., Teixeira, M. M., Dos Santos, R. A. S., Guimarães, P. P. G., & Frézard, F. (2024). Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00835-24

Vancouver

Mendes S, Guimarães LC, Costa PAC, Fernandez CC, Figueiredo MM, Teixeira MM, et al. Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00835-24

BibTeX
@article{Mendes2024,
  author = {Mendes, Sabrina and Guimarães, Lays Cordeiro and Costa, Pedro Augusto Carvalho and Fernandez, Clara Couto and Figueiredo, Maria Marta and Teixeira, Mauro Martins and Dos Santos, Robson Augusto Souza and Guimarães, Pedro Pires Goulart and Frézard, Frédéric},
  title = {Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00835-24}
}
Kostenlos starten →